Explore the cutting-edge of cognitive therapeutics in Precision Neuroscience: Targeting NMDA Receptor Subunits in Cognitive Disorders. Learn how NMDA receptor subunit dysfunction drives cognitive deficits in schizophrenia, Alzheimer’s, stroke, TBI, and ADHD, and discover how subunit-selective modulators (NR2A, NR2B, NR2D) offer precision strategies to restore synaptic plasticity, network function, and cognitive performance. Ideal for neuroscientists, clinicians, and translational researchers.
